Comparable stake leader
L.I.A. Pure Capital Ltd
SEC ownership of Evogene Ltd.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001574565.
Disclosed value leader
L.I.A. Pure Capital Ltd
Comparable rows
15/16
Latest evidence
11 Aug 2026
- Public ticker
- EVGN on Nasdaq
- Parsed ownership sources
-
13D/G, 3/4/5, and 13F
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
L.I.A. Pure Capital Ltd
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
15 of 16
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
L.I.A. Pure Capital Ltd
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
11 Aug 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001574565
- Issuer location
- Rehovot, Israel
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Evogene Ltd. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
L.I.A. Pure Capital Ltd
Disclosed value leader
L.I.A. Pure Capital Ltd
Comparable rows
15/16
Latest evidence
11 Aug 2026
13D/G
3/4/5
13F
Lead comparable stake: 19%
1 rows are not safely comparable across share classes.
13D/G row: L.I.A. Pure Capital Ltd
Showing 1-8 of 16 holder rows.
Quick read
L.I.A. Pure Capital Ltd leads the comparable SEC ownership view at 19%.
15 of 16 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens L.I.A. Pure Capital Ltd's linked filing trail.
Comparable ownership
Top 5
L.I.A. Pure Capital Ltd
19%
Leon Recanati
8.6%
ARMISTICE CAPITAL, LLC
5%
HRT FINANCIAL LP
0.75%
SUSQUEHANNA INTERNATIONAL GROUP, LLP
0.56%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 16 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| L.I.A. Pure Capital Ltd |
13D/G
|
19%
|
$1,406,444
3,057,488 shares
|
+$245,220 | 10 Aug 2026 |
| Leon Recanati |
3/4/5
13D/G
Director · RECANATI LEON
|
8.6%
from 13D/G
|
$854,517
1,346,386 shares
mixed-class rows
|
+$692,100 | 11 Aug 2026 |
| ARMISTICE CAPITAL, LLC |
13D/G
|
5%
|
$328,228
713,539 shares
|
$0 | 30 Jun 2026 |
| HRT FINANCIAL LP |
13F
Company
|
0.75%
|
$45,000
107,198 shares
|
— | 30 Jun 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
Company
|
0.56%
|
$33,889
80,078 shares
|
— | 30 Jun 2026 |
| CITADEL ADVISORS LLC |
13F
Company
|
0.35%
|
$21,383
50,526 shares
|
— | 30 Jun 2026 |
| XTX Topco Ltd |
13F
Company
|
0.14%
|
$8,212
19,404 shares
|
— | 30 Jun 2026 |
| UBS Group AG |
13F
Company
|
0.08%
|
$4,737
10,790 shares
|
— | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to buying over the last 12 months. Net value: +$692,100.
Buys
$692,100
Insiders: 1
Sells
$0
Insiders: 0
Net
+$692,100
Shares: +1,260,000
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 1,260,000
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 1,260,000 | 0 | $692,100 | $0 | +$692,100 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-10 of 10 reporting-owner rows connected to Evogene Ltd.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
10
Largest Forms 3/4/5 holder
Leon Recanati
Net 12M change
+$692,100
Latest report
11 Aug 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Leon Recanati | Director | $854,517 | +$692,100 | +426% | Mixed | 11 Aug 2026 |
| Adrian John Percy | Director | Mixed | 18 Mar 2026 | |||
| Nir Nimrodi | Director | Mixed | 18 Mar 2026 | |||
| Ofer Haviv | President and CEO, Director | Mixed | 18 Mar 2026 | |||
| Yaron Eldad | Chief Financial Officer | Mixed | 18 Mar 2026 | |||
| Dan Michael Falk | Director | Mixed | 18 Mar 2026 | |||
| Ilia Zhidkov | Chief Technology Officer | Mixed | 18 Mar 2026 | |||
| Gabi Tarcic | Chief Development Officer | Mixed | 18 Mar 2026 | |||
| Polina Ravzin | VP Finance | Mixed | 01 Apr 2026 | |||
| Sarit Firon | Director | Mixed | 18 Mar 2026 |
Recent insider transactions for Evogene Ltd.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Leon Recanati | EVGN | Ordinary Shares | Purchase | 52% | $292,100 | $0.6350 | 460,000 | 1,343,886 | 11 Aug 2026 | Direct |
| Leon Recanati | EVGN | Ordinary Shares | Purchase | 953.7% | $400,000 | $0.5000 | 800,000 | 883,886 | 04 Aug 2026 | Direct |
* marks a reported price that did not pass the local price check.